1. Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium
   Rafael Ríos et al, 2015, Endocrine-Related Cancer CrossRef
2. Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients
   Elena L'vovna Nazarova et al, 2018, Clinical oncohematology CrossRef
3. Анемічний синдром в комплексі клініко-гематологічних проявів множинної мієломи на Закарпатті
   М. Yu. Popovych, 2022, Likarska sprava CrossRef
4. Could age modify the effect of genetic variants in IL6 and TNF-α genes in multiple myeloma?
   Alessandro Martino et al, 2012, Leukemia Research CrossRef